Recent updates

Browse recent updates. BMJ Best Practice is continuously updated to provide the latest evidence-based decision support.

  • 04 Nov 2026New human H5N1 cases linked to dairy cattle outbreak in Washington StateTopic:Avian influenza A (H5N1) virus infection
  • 03 Nov 2026Outbreak in DRC now the second-largest ever in history; expands to Kenya and NigeriaTopic:Ebola disease
  • 30 Oct 2026Bepirovirsen approval offers new option for treatment of chronic HBV infectionTopic:Hepatitis B
  • 30 Sep 2026GINA develops updated assessment and treatment recommendations with new flowcharts for acute asthma exacerbationTopic:Acute asthma exacerbation in adults
  • 09 Sep 2026CDC recommends extended 5-day treatment course of artemether/lumefantrineTopic:Malaria
  • 02 Sep 2026Global consensus to rename polycystic ovary syndromeTopic:Polycystic ovary syndrome
  • 23 Jul 2026Imaging-based artificial intelligence (AI) models for breast cancer risk assessment added to US guidelinesTopic:Primary invasive breast cancer
  • 22 Jul 2026WHO declares cruise ship outbreak overTopic:Hantavirus cardiopulmonary syndrome
  • 07 Jul 2026US guidance encourages prompt diagnosis and treatment of patients with endometrial cancer.Topic:Endometrial cancer
  • 07 Jul 2026US guidance encourages prompt diagnosis and treatment of patients with endometrial cancer.Topic:Evaluation of vaginal bleeding
  • 07 Jul 2026Guidelines recommend long-acting injectable PrEP and a two-drug ART alternative initial regimen as options during pregnancy and breastfeeding​Topic:HIV in pregnancy
  • 30 Jun 2026Bulevirtide: the first FDA-approved treatment for chronic hepatitis DTopic:Hepatitis D
  • 12 Jun 2026FDA approves first and only oral option for COVID-19 postexposure prophylaxisTopic:Coronavirus disease 2019 (COVID-19)
  • 22 May 2026FDA expands approval of teplizumab to include children aged ≥1 yearTopic:Type 1 diabetes mellitus
  • 15 May 2026US cervical cancer screening guidelines include the option of self-collection of vaginal samplesTopic:Cervical cancer
  • 14 May 2026Tazemetostat withdrawn globally for all indications (including follicular lymphoma) due to risk of secondary hematologic malignanciesTopic:Non-Hodgkin lymphoma
  • 06 May 2026FDA approves new oral antibiotics effective against resistant strains of gonorrheaTopic:Urethritis